Skip to content

Clinical trials

Phase 1/2 Neoplasm Metastasis trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 1/2 Country / region: South Korea Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20131
20162
20191
20204
20217
20225
20233
20242
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting18
Active, not recruiting6
Completed4
Terminated4
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GI Innovation, Inc.3
Ascendis Pharma Oncology Division A/S2
AstraZeneca2
Merck Sharp & Dohme LLC2
Novartis Pharmaceuticals2
Nuvalent Inc.2
Turning Point Therapeutics, Inc.2
CJ Bioscience, Inc.1
Crescent Biopharma, Inc.1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis33
Carcinoma, Non-Small-Cell Lung12
Lung Neoplasms6
Colorectal Neoplasms5
Squamous Cell Carcinoma of Head and Neck5
Breast Neoplasms4
Carcinoma, Renal Cell4
Endometrial Neoplasms4
Uterine Cervical Neoplasms4
Melanoma3

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.